$22 biotech stock to double by the year end
by java106 | October 8, 2013 1:20 pm
I got an email from Louis Navellier[1] touting /guaranteeing a $22 biotech stock to double by the year end. He will reveal the name of the stock if you buy subscription to his newsletter for $295 for the quarter or $995 yearly. Does any one have an opinion about Louis Navellier and his newsletter? Any feedback would be much appreciated.
Regards,
Ikbal
Endnotes:
- Louis Navellier: https://www.stockgumshoe.com/tag/louis-navellier/
Source URL: https://www.stockgumshoe.com/2013/10/microblog-22-biotech-stock-to-double-by-the-year-end/
Thanks all for the great input on Navellier’s newsletter and specially to Travis for a very thorough write up on SNTS
Regards,
Ikbal
No doubt it is Santus,snts./I bought the stock 2 months ago. It’s just been hanging around 21. to 22.09.
Thanks for giving me the ticker symbol. I was quite curious. I am new to financial news reports and investing in stocks and am not sure who will give the best advise. Everyone sounds so “sincere.” I’ll check out snts
Wow, I looked at SNTS and it gapped up to about 32 from 22. I’ve only heard good things about Navalier. He has often been rated the #1 rated newsletter for longer term investing, and I did not realize he has shorter term trade ideas.
Yes, Navellier’s letters have had some good multi-year runs, particularly in bull markets. This one was a “short term promise” indication that he thought it would boom on earnings as their product sales ramped up, which may or may not have played out as he planned, but he also got lucky with the buyout offer.